Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:5.99.1.2 (
topoisomerase
)
9,166
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The t(8;13)(p11;q12) is the most common translocation associated with the 8p11 myeloproliferative syndrome and results in an identical mRNA fusion between
ZNF198
at 13q12 and FGFR1 at 8p11 in all cases thus far reported.
ZNF198
is a widely expressed gene that is predicted to encode a 1377-amino-acid protein with five Zn finger-related motifs known as MYM domains. To determine the genomic DNA structure of
ZNF198
, we employed bubble PCR from PAC clones with a panel of gene-specific primers. Sequencing of these products revealed that
ZNF198
consists of 26 exons with the initiation codon located in exon 4. The t(8;13) results in a consistent mRNA fusion of
ZNF198
exon 17 to FGFR1 exon 9. Notable features of the structure of
ZNF198
include three noncanonical GC donor splice sites and the presence of an alternatively spliced intron within exon 4. Amplification of genomic DNA from six t(8;13) patients with primers to
ZNF198
exon 17 and FGFR1 exon 9 yielded patient-specific products ranging in size from 500 bp to 2.5 kb, indicating that the positions of the breakpoints in the t(8;13) are tightly clustered. The positions of the six t(8;13) breakpoints were determined and found to be distributed across
ZNF198
intron 17 and FGFR1 intron 8 with no apparent subclustering. No consistent sequence motifs, repeats, or
topoisomerase
II cleavage sites were found at or near the breakpoints. It remains unclear why the t(8;13) translocation breakpoints occur within such small genomic regions, and it is possible that strict
ZNF198
-FGFR1 coding requirements restrict the positions of the breakpoints.
...
PMID:The genomic structure of ZNF198 and location of breakpoints in the t(8;13) myeloproliferative syndrome. 988 6